Venture capital financing

Infinity Stone Ventures Announces Consolidation of its Shares

Retrieved on:

Tuesday, July 11, 2023

CSE, Infinity Stones, Canadian Securities Exchange, FSE, Share (finance), Corporation, OTC, Consolidation, ISIN, CUSIP, DRS, Letter, Venture capital financing, Security (finance)

VANCOUVER, British Columbia, July 11, 2023 /PRNewswire/ -- Infinity Stone Ventures Corp. (CSE: GEMS) (OTC: GEMSF) (FSE: B2I) (the "Company" or "Infinity Stone"), announces it is consolidating all of its Class A Subordinate Voting shares ("Class A Shares") and Class B Super Voting Shares ("Class B Shares") on the basis of one post-consolidated Class A Share or Class B Share for every two pre-consolidated Class A Shares or Class B Shares held, as the case may be (the "Consolidation").

Key Points:

VANCOUVER, British Columbia, July 11, 2023 /PRNewswire/ -- Infinity Stone Ventures Corp. (CSE: GEMS) (OTC: GEMSF) (FSE: B2I) (the "Company" or "Infinity Stone"), announces it is consolidating all of its Class A Subordinate Voting shares ("Class A Shares") and Class B Super Voting Shares ("Class B Shares") on the basis of one post-consolidated Class A Share or Class B Share for every two pre-consolidated Class A Shares or Class B Shares held, as the case may be (the "Consolidation").
The Consolidation affects all the Company's Class A and Class B shares outstanding on July 14, 2023.
The Class B shares will be reduced to approximately 16,894 from 33,788, also subject to the treatment of fractional shares.
Infinity Stone's Class A Shares will continue to trade under the symbol "GEMS" and Infinity Stone's name will not change.

Infinity Stone Ventures Announces Consolidation of its Shares

Retrieved on:

Tuesday, July 11, 2023

CSE, Infinity Stones, Canadian Securities Exchange, FSE, Share (finance), Corporation, OTC, Consolidation, ISIN, CUSIP, DRS, Letter, Venture capital financing, Security (finance)

VANCOUVER, British Columbia, July 11, 2023 /PRNewswire/ -- Infinity Stone Ventures Corp. (CSE: GEMS) (OTC: GEMSF) (FSE: B2I) (the "Company" or "Infinity Stone"), announces it is consolidating all of its Class A Subordinate Voting shares ("Class A Shares") and Class B Super Voting Shares ("Class B Shares") on the basis of one post-consolidated Class A Share or Class B Share for every two pre-consolidated Class A Shares or Class B Shares held, as the case may be (the "Consolidation").

Key Points:

VANCOUVER, British Columbia, July 11, 2023 /PRNewswire/ -- Infinity Stone Ventures Corp. (CSE: GEMS) (OTC: GEMSF) (FSE: B2I) (the "Company" or "Infinity Stone"), announces it is consolidating all of its Class A Subordinate Voting shares ("Class A Shares") and Class B Super Voting Shares ("Class B Shares") on the basis of one post-consolidated Class A Share or Class B Share for every two pre-consolidated Class A Shares or Class B Shares held, as the case may be (the "Consolidation").
The Consolidation affects all the Company's Class A and Class B shares outstanding on July 14, 2023.
The Class B shares will be reduced to approximately 16,894 from 33,788, also subject to the treatment of fractional shares.
Infinity Stone's Class A Shares will continue to trade under the symbol "GEMS" and Infinity Stone's name will not change.

Acepodia Secures $100 Million Series D Financing to Advance

Retrieved on:

Tuesday, June 6, 2023

ACC, Nobel Prize, Genetic engineering, Nobel Prize in Chemistry, Venture round, Cancer, CD20, Research, Click chemistry, Hematological Cancer Research Investment and Education Act, Patient, Non-Hodgkin lymphoma, Venture capital financing, Vaccine, Chemistry

ALAMEDA, Calif. and TAIPEI, June 6, 2023 /PRNewswire/ -- Acepodia, a clinical stage biotechnology company developing first-in-class cell therapies with its unique Antibody-Cell Conjugation (ACC) and allogeneic gamma delta 2 T-cell platforms to address gaps in cancer care, today announced a $100 million Series D financing led by Digital Mobile Venture with participation from additional existing investors. The funds will be used to progress the company's pipeline of enhanced cell therapies for solid tumors and hematologic cancers, including ACE1831 and ACE2016. ACE1831 is an anti-CD20 armed allogeneic gamma delta 2 T-cell therapy currently being studied in a Phase 1 trial for patients with non-Hodgkin Lymphoma. ACE 2016 is an anti-EGFR armed allogeneic gamma delta 2 T-cell therapy targeting EGFR-expressing solid tumors.

Key Points:

ACE1831 is an anti-CD20 armed allogeneic gamma delta 2 T-cell therapy currently being studied in a Phase 1 trial for patients with non-Hodgkin Lymphoma.
"This financing illustrates the confidence of Acepodia's current investors in our team, our mission, and our differentiated platform, and we are extremely grateful for their support," said Sonny Hsiao, Ph.D., chief executive officer of Acepodia.
Acepodia has raised $259 million to date in venture capital financing, including a $109 million Series C round completed in December 2021.
Returning investors in the Series D included Digital Mobile Venture as the lead investor.

Finovance Technologies, Inc., a New Leading AI and ML Based Non-Bank Fintech Capital and Payments Provider to SMB Businesses, Announces the Closing of Initial Funding and Emergence from Stealth Development

Retrieved on:

Thursday, May 25, 2023

Fintech, Small business, SAAS, Silicon Valley Bank, ML, Luigi, SMB, Silicon, RBF, Machine learning, Artificial intelligence, Growth, Signature Bank, First Republic Bank, Venture capital financing, Cryptocurrency, Bank

San Francisco, California and London United Kingdom--(Newsfile Corp. - May 24, 2023) - Finovance, a leading artificial intelligence "AI'' and machine learning "ML" revenue-based financing "RBF" and payments fintech capital provider to small and medium-sized businesses (SMBs), raised an undisclosed amount in initial seed funding. Finovance will use the funds to expand operations and add additional financing offerings to empower SMBs to better manage their working capital needs as well as visualize their own financial data.

Key Points:

If the advance release of Finovance AI and ML solutions is any sign of this unmet demand, entrepreneurs and small business owners alike know something special has been built at Finovance.
San Francisco, California and London United Kingdom--(Newsfile Corp. - May 24, 2023) - Finovance , a leading artificial intelligence "AI'' and machine learning "ML" revenue-based financing "RBF" and payments fintech capital provider to small and medium-sized businesses (SMBs), raised an undisclosed amount in initial seed funding.
Finovance has spent over two years developing its innovative and proprietary technology stack and recently emerged from stealth mode to debut www.Finovance.com .
Finovance is positioned as an alternative financing solution to traditional banks, private equity, and/or venture capital financing.

Acadian Ventures Launches the Future of Work 100

Retrieved on:

Wednesday, May 24, 2023

Technology, Software, History of organizations, Breeding, Work, Rising Star, Research, Future, Silicon, ARR, The Future of Work and Death, Survival, Growth, Comer's Midden, Venture capital financing, Renewable energy, Oyster

Acadian Ventures , an early stage venture capital firm, launched its inaugural Future of Work 100 today.

Key Points:

Acadian Ventures , an early stage venture capital firm, launched its inaugural Future of Work 100 today.
The Future of Work 100 is the first list to recognize the leading venture-backed companies that are enabling how work gets done in the future.
The Future of Work 100 is highly representative of the global nature of work today.
“Our vision for the Future of Work 100 is to highlight the importance of work technologies and recognize the leading companies that are building the tools and technologies that will define work in the future,” said Jason Corsello, general partner at Acadian Ventures.

InProTher Announces EUR 6M Seed Financing with the Participation of the European Innovation Council Fund to Develop First-In-Class Cancer Immunotherapy

Retrieved on:

Wednesday, May 24, 2023

The financing will enable InProTher to advance its lead drug candidate, IPT001, a first-in-class immunotherapy against solid tumors, into clinical development.

Key Points:

The financing will enable InProTher to advance its lead drug candidate, IPT001, a first-in-class immunotherapy against solid tumors, into clinical development.
InProTher has generated robust pre-clinical, proof-of-concept data that demonstrates therapeutic potential for multiple oncology indications including pancreatic, ovarian, breast and prostate cancer.
Jordi Naval, Chief Executive Officer of InProTher said: "InProTher is shifting the paradigm in cancer immunotherapy and is at an exciting phase of growth.
The Seed round of EUR 6M includes private investors and a convertible loan from EICF.

InProTher Announces EUR 6M Seed Financing with the Participation of the European Innovation Council Fund to Develop First-In-Class Cancer Immunotherapy

Retrieved on:

Wednesday, May 24, 2023

The financing will enable InProTher to advance its lead drug candidate, IPT001, a first-in-class immunotherapy against solid tumors, into clinical development.

Key Points:

The financing will enable InProTher to advance its lead drug candidate, IPT001, a first-in-class immunotherapy against solid tumors, into clinical development.
InProTher has generated robust pre-clinical, proof-of-concept data that demonstrates therapeutic potential for multiple oncology indications including pancreatic, ovarian, breast and prostate cancer.
Jordi Naval, Chief Executive Officer of InProTher said: "InProTher is shifting the paradigm in cancer immunotherapy and is at an exciting phase of growth.
The Seed round of EUR 6M includes private investors and a convertible loan from EICF.

Canadian Venture Capital funding falls off a cliff in Q1, 2023

Retrieved on:

Friday, May 19, 2023

Canadian venture capital (VC) disbursements barely passed the $1 billion mark, completing 141 financing for $1,064 billion in Q1 2023.

Key Points:

Canadian venture capital (VC) disbursements barely passed the $1 billion mark, completing 141 financing for $1,064 billion in Q1 2023.
US and international investors invested $479 million and $107million or 45% and 10% of the total disbursements respectively in Q1 2023.
US investors maintained its relative share in Canadian VC funding, unchanging from its 45% share in 2022.
Canadian investors invested $479 million, increasing its relative share to 45%, absorbing funding loss from international investors.

Artesian Resources Corporation Reports First Quarter 2023 Results

Retrieved on:

Tuesday, May 9, 2023

Diluted net income per share decreased 17.0% to $0.39 for the three months ended March 31, 2023 compared to $0.47 for the first quarter of 2022.

Key Points:

Diluted net income per share decreased 17.0% to $0.39 for the three months ended March 31, 2023 compared to $0.47 for the first quarter of 2022.
Earnings in the first quarter this year were significantly impacted by continuing inflationary pressures, increased depreciation expense, increased short-term interest rates, and certain non-recurring expenses.
The rate filing seeks recovery of the significant necessary investments made in utility plant since our last filing in 2014, as well as recognition of increased operating costs,” said Nicki Taylor, President of Artesian Water Company, Inc. (“Artesian Water”), the principal subsidiary of Artesian Resources Corporation.
The PSC approved the change in the first quarter of 2023, with it retroactively effective to February 2022, resulting in a $0.1 million reduction in Artesian Water’s revenue in the first quarter of 2023.

SunPower Invests in Wolf River Electric, Expanding Solar Footprint in the Midwest

Retrieved on:

Thursday, April 27, 2023

SunPower, EV, Corporation, Venture capital financing, Corporate development, Renewable energy

RICHMOND, Calif., April 27, 2023 /PRNewswire/ -- SunPower (NASDAQ:SPWR), a leading solar technology and energy services provider, announced it made a minority investment in one of the largest residential solar providers in Minnesota, Wolf River Electric. Through this relationship, Wolf River is expected to accelerate its already high growth trajectory in Minnesota alongside a growing presence in Iowa and Wisconsin, enabling the companies to serve more customers in the market and increase solar adoption in historically underpenetrated areas.

Key Points:

Wolf River will sell SunPower® solar, SunVault® battery storage, EV charging equipment and financial products on an exclusive basis for the next five years.
The dealer's volume in the three states creates a significant net-new geographic coverage opportunity for SunPower to accelerate adoption in the Midwest.
Additionally, Wolf River shares SunPower's value for delivering superior customer experience as a top rated solar company currently with a 4.8 star rating on Google.
Chardan investment bank acted as the exclusive financial advisor to Wolf River in this transaction, led by Elliot Gnedy, Director.